Intech Investment Management LLC Makes New $815,000 Investment in ICU Medical, Inc. (NASDAQ:ICUI)

Intech Investment Management LLC bought a new stake in ICU Medical, Inc. (NASDAQ:ICUI) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 4,474 shares of the medical instruments supplier’s stock, valued at approximately $815,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Russell Investments Group Ltd. grew its holdings in shares of ICU Medical by 46.4% in the first quarter. Russell Investments Group Ltd. now owns 546 shares of the medical instruments supplier’s stock valued at $59,000 after purchasing an additional 173 shares during the period. CANADA LIFE ASSURANCE Co increased its stake in ICU Medical by 1.7% during the first quarter. CANADA LIFE ASSURANCE Co now owns 20,505 shares of the medical instruments supplier’s stock worth $2,201,000 after acquiring an additional 343 shares during the last quarter. Jane Street Group LLC raised its position in ICU Medical by 79.7% in the first quarter. Jane Street Group LLC now owns 89,852 shares of the medical instruments supplier’s stock valued at $9,643,000 after purchasing an additional 39,839 shares during the period. Virtu Financial LLC acquired a new position in shares of ICU Medical in the 1st quarter valued at $288,000. Finally, Boston Partners purchased a new position in shares of ICU Medical during the 1st quarter worth $790,000. 96.10% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at ICU Medical

In other ICU Medical news, COO Christian B. Voigtlander sold 1,962 shares of the business’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $169.08, for a total transaction of $331,734.96. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Vivek Jain sold 12,000 shares of the business’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $178.46, for a total transaction of $2,141,520.00. Following the completion of the sale, the chief executive officer now owns 104,593 shares in the company, valued at $18,665,666.78. This represents a 10.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 40,364 shares of company stock valued at $6,876,478. 6.70% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on ICUI shares. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. Raymond James lifted their target price on shares of ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a report on Thursday, September 12th. KeyCorp boosted their target price on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research report on Wednesday, November 13th. Jefferies Financial Group initiated coverage on ICU Medical in a research report on Monday, October 14th. They set a “hold” rating and a $183.00 price target for the company. Finally, StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, ICU Medical currently has an average rating of “Moderate Buy” and an average target price of $173.00.

ICU Medical Trading Up 1.3 %

Shares of ICU Medical stock opened at $159.75 on Friday. The company’s fifty day moving average is $175.28 and its two-hundred day moving average is $146.60. ICU Medical, Inc. has a 1 year low of $83.26 and a 1 year high of $196.26. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The company has a market capitalization of $3.91 billion, a P/E ratio of -34.96 and a beta of 0.66.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.